Literature DB >> 11083046

Comparison of different methods of diagnosis of cystic ovarian disease in cattle and an assessment of its treatment with a progesterone-releasing intravaginal device.

R Douthwaite1, H Dobson.   

Abstract

The aims of this study were to assess the accuracy of different common methods of differentiating between follicular and luteal ovarian cysts, and to monitor the response of the cysts to 12 days treatment with a progesterone-releasing intravaginal device (PRID). On the basis of agreement between the different methods, 25 of the 46 cases examined were diagnosed as follicular and 14 as luteal cysts; for the other seven cases the methods disagreed. The use of ultrasound was more accurate in diagnosing follicular cysts than luteal cysts, and combined with plasma progesterone concentrations gave the most accurate assessment of cyst type (92 per cent for follicular cysts and 82 per cent for luteal cysts). The mean (se) plasma progesterone concentration was lower in the cows with follicular cysts than in those with luteal cysts (0.29 [0.05] v 3.90 [0.63] ng/ml; P<0.05). Luteal cysts had thicker walls (5.3 [0.04] v 2.5 [0.2] mm; P<0.0001), and the wall thickness of all the cysts was positively correlated with plasma progesterone concentration (r=0.52, P<0.0004). Cows with luteal cysts had more additional follicles greater than 5 mm in diameter (P<0.01). In cows with follicular cysts and other follicles greater than 5 mm in diameter, the mean oestradiol concentration was 7.9 (1.8) pg/ml compared with 24.2 (3.1) pg/ml (P=0.002) in cows without other follicles greater than 5 mm in diameter on either ovary. At the time of PRID removal, plasma progesterone concentration had increased in the cows with follicular cysts to 1.59 (0.06) ng/ml (P<0.05) and decreased in the cows with luteal cysts to 0.87 (0.01) ng/ml (P<0.05), although there was no change in original cyst structure in 45 per cent of the cases. However, new ovarian structures were frequently observed during the treatment. The overall pregnancy rate for cows with both types of cyst after treatment was 50 per cent after three inseminations, but the first service pregnancy rate was only 18 per cent for cows with follicular cysts and 28 per cent for cows with luteal cysts. After treatment, the fertility of cows with follicular cysts was similar to that of paired herdmates, whereas cows with luteal cysts took 40 days longer to calve again than healthy herdmates. However, the culling rate was higher for cows with follicular cysts (41 v 11 per cent).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083046     DOI: 10.1136/vr.147.13.355

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  5 in total

1.  Recovery rate and recovery time in cows with luteal and follicular ovarian cysts after treatment with buserelin.

Authors:  M C Veronesi; M Battocchio; F Cairoli; A Comin; M Isola
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

2.  Reproductive performance in dairy cows with cystic ovarian disease after single treatment with buserelin acetate or dinoprost.

Authors:  Silviu Ionut Borș; Iulian Ibănescu; Șteofil Creangă; Alina Borș
Journal:  J Vet Med Sci       Date:  2018-05-30       Impact factor: 1.267

3.  Reproductive responses of dairy cows with ovarian cysts to simultaneous human chorionic gonadotropin or gonadotropin-releasing hormone and cloprostenol compared to gonadotropin-releasing hormone alone treatment.

Authors:  T Taktaz; M Kafi; Adel Mokhtari; M Heidari
Journal:  Vet World       Date:  2015-05-22

Review 4.  Ovarian cysts, an anovulatory condition in dairy cattle.

Authors:  Silviu-Ionuț BorŞ; Alina BorŞ
Journal:  J Vet Med Sci       Date:  2020-08-18       Impact factor: 1.267

5.  Early Warning for Ovarian Diseases Based on Plasma Non-esterified Fatty Acid and Calcium Concentrations in Dairy Cows.

Authors:  Yuxi Song; Jiaxin Cheng; Hang Yu; Zhijie Wang; Yunlong Bai; Cheng Xia; Chuang Xu
Journal:  Front Vet Sci       Date:  2021-12-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.